<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83927">
  <stage>Registered</stage>
  <submitdate>14/05/2009</submitdate>
  <approvaldate>12/06/2009</approvaldate>
  <actrnumber>ACTRN12609000441213</actrnumber>
  <trial_identification>
    <studytitle>A Probiotic Preparation of Bacillus coagulans: Is It a
Viable Adjunct Therapy for Relieving Symptoms of Osteoarthritis?</studytitle>
    <scientifictitle>A Randomized, Placebo-Controlled Trial of a Patented Preparation of Bacillus coagulans as Adjunct Therapy for the Relief of Symptoms in Osteoarthritis</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>mild to moderate osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Bacillus coagulans GBI-30, 6086 is a patented strain of probiotic lactic-acid producing bacteria. It was taken in caplet form orally with water once daily for up to 60 days. Each caplet/dose contained 2 x 10 9 colony-forming units (CFUs).</interventions>
    <comparator>Identically appearing placebo caplet (985 mg) containing microcrystalline cellulose was taken orally with water once daily for 60 days,</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Measures of functional capacity and  symptom severity of osteoarthritis affecting the knee or back. Patients were assessed at baseline, 30 days, and 60 days from the start of treatment using the Knee Injury and Osteoarthritis Outcome Scale (KOOS) or the Oswestry Disability Questionnaire.</outcome>
      <timepoint>60 days following the commencement of treatment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety. Adverse events such as gas, cramps, or diarrhea were reported directly to each investigator.</outcome>
      <timepoint>60 days following the commencement of treatment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult men and women with a documented history of mild to moderate osteoarthritis for at least 12 months and had not started any new therpay within the last 3 months</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>64</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women of child bearing age, current probiotic usage, antibiotic therapy over the last 2 weeks, no new therapy within the last 3 months, kidney and liver disease</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/07/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>33</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Keith Lamberson, MD</primarysponsorname>
    <primarysponsoraddress>Pinnacle Orthopedics &amp; Sports Medicine Specialists
1668 Mulkey Road
Austell, GA  30106</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Ganeden Biotech Inc.</fundingname>
      <fundingaddress>5915 Landerbrook Dr. Suite 304
Mayfield Heights, OH  44124</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Certain probiotics have demonstrated the ability to lessen the symptoms of arthritis in animals and humans. This clinical trial was conducted to evaluate the effects of the probiotic Bacillus coagulan GBI-30, 6086 as adjunct therapy for the relief of symptoms of mild to moderate osteoarthritis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sterling Institutional Review Board (Atlanta, GA)</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Keith Lamberson, MD</name>
      <address>Pinnacle Orthopedics &amp; Sports Medicine Specialists
1668 Mulkey Road
Austell, GA  30106</address>
      <phone>1-770-944-3303</phone>
      <fax />
      <email>keithlamberson@msn.com</email>
      <country>United States of America</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Keith Lamberson, MD</name>
      <address>Pinnacle Orthopedics &amp; Sports Medicine Specialists
1668 Mulkey Road
Austell, GA  30106</address>
      <phone>1-770-944-3303</phone>
      <fax />
      <email>keithlamberson@msn.com</email>
      <country>United States of America</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>